| Name | Birth year | Position |
| Dr. h.c. mult. Hansjörg Wyss | 1935 | Chairman of the Board |
| Michel Orsinger | 1957 | President and CEO |
| Robert Donohue | 1947 | CFO |
| Ciro Römer | 1962 | President Europe, Middle East and Africa & Global Operations |
Dr. h.c. mult. Hansjörg Wyss (MD), Swiss citizen, is Chairman of Synthes, Inc. and has held this position since its founding in 1999. From 1977 until 2007 he held the position of CEO for Synthes, Inc. and its predecessor organization. Prior to his involvement with the Company, he served in management roles at several European corporations, including Director of Monsanto Europe SA; President-Managing Director of Schappe-Burlington AG and Assistant to the President of Burlington International. In 2004, Mr. Wyss was awarded his first Honorary Doctorate by the University of Basel, Switzerland, and in 2005 honored with another Honorary Doctorate from Paracelsus Medical University in Salzburg, Austria. In 2009, he was awarded a third Honorary Doctorate of Engineering by Clemson University, U.S.A. Education: MBA with distinction, Harvard Business School (U.S.A.); M.Sc. in Civil and Structural Engineering, Swiss Federal Institute of Technology, Zurich (Switzerland).
Mr. Michel Orsinger, Swiss citizen, is the President and has held the position of CEO of Synthes, Inc. since 2007. He joined the Company in 2004 when he was retained as Chief Operating Officer. Prior to this, he spent ten years with Novartis in various executive management positions, most recently as President and CEO of OTC Worldwide. Mr. Orsinger served as a member of the Nobel Biocare Board of Directors from 2004 to 2006. Education: Business Administration Degree, University of St. Gallen (Switzerland); Advanced Management Program, Harvard Business School (U.S.A.); Advanced Management Program, INSEAD (France).
Mr. Robert Donohue, U.S. citizen, has held the position of CFO of Synthes, Inc. since 1998. He is responsible for Synthes, Inc.’s financial reporting, internal controls and related issues. Additionally, he holds the position of President, Synthes Canada, Ltd.. Prior to this, Mr. Donohue held the position of Vice President of Finance for Synthes (U.S.A). He has been with Synthes since 1990 when he was retained as Corporate Controller. Prior to joining the Company, he served in several financial positions, including corporate controller and plant controller with several major U.S. corporations. Education: B.Sc. in Economics, West Chester University; MBA, Widener University (both U.S.A.); Certified Public Accountant.
Mr. Ciro Römer, Dutch citizen, has been the President of Europe, Middle East and Africa since 2003 and additionally has held the position of President Global Operations since 2008. Prior to this, he held the positions of Vice President Europe as well as General Manager for the Netherlands and Spain. Between 1983 and 1998 Mr. Römer held various positions at the OLVG clinic and at Howmedica. He has over twenty years experience in the orthopedic industry. Education: Radulphus College (Netherlands); Advanced Management Program, Harvard Business School (U.S.A.).




